Purinergic signaling promotes gliomagenesis through nuclear calcium transients
Wang, S.; Richter, J.; Kim, C.; Ronnen, R.; Cai, J.; Song, Y.; Haddock, S.; Stoessel, M.; Dada, H.; Gross, S.; Guerrero, A.; Karnavas, T.; Stephan, G.; Belizaire, G.; Bonanni, L.; Golub, D.; Sabio, J.; Schwarz, H.; Jiang, A.; Maleeha, N.; Ghosh, A.; Yung, M.; Grossman-Glover, E.; Tang, J.; Gherghina, L.; Donovan, A.; Leonard, A.; Chiriboga, L.; Jones, D. R.; Song, S. C.; Mazzoni, E.; Vincent, T.; Schneider, R. J.; Zagzag, D.; Miura, Y.; Basu, J.; Brand, A. H.; Placantonakis, D. G.
Show abstract
Intracellular Ca2+ transients drive key developmental and physiological processes, yet their role in oncogenesis remains incompletely understood. In glioblastoma (GBM), an aggressive brain malignancy, tumor cellular networks exhibit self-sustaining Ca2+ transients that promote tumor growth through unclear mechanisms. Using patient-derived GBM models, we show that these transients depend primarily on intracellular Ca2+ stores and extend to the nucleus to drive tumorigenesis. A neuromodulator screen identified extracellular purines ATP and ADP as potent inducers of both nuclear and cytosolic Ca2+ transients via activation of metabotropic purinergic P2RY1 receptors, whose knockdown attenuates tumorigenicity in vitro and in vivo. Mechanistically, Ca2+ transients promote tumorigenesis via the nuclear Ca2+/calmodulin-dependent kinase CAMK4, which regulates transcriptional and epigenetic programs, as well as ribosomal DNA transcription. From the therapeutic perspective, pharmacologic P2RY1 inhibition suppresses tumor growth in vitro and in vivo. Collectively, these findings reveal a pharmacologically targetable oncogenic mechanism in GBM and possibly other malignancies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition 96%
- SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia 96%
- PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma 95%
Similar papers in this journal
- EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma 96%
- Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells 95%
- Distinct Tumor-TAM Interactions in IDH-Stratified Glioma Microenvironments unveiled by Single-Cell and Spatial Transcriptomics 94%
Similar papers in this journal
Similar papers in this journal
- GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis 95%
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor 95%
- NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors 94%
Similar papers in this journal
- The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability 96%
- Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis 96%
- Super elongation complex as a targetable dependency in diffuse midline glioma 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.